{"id":29807,"date":"2026-11-09T16:08:33","date_gmt":"2026-11-09T19:08:33","guid":{"rendered":"https:\/\/femama.org.br\/site\/?p=29807"},"modified":"2026-11-09T16:23:30","modified_gmt":"2026-11-09T19:23:30","slug":"vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/","title":{"rendered":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Na \u00faltima quinta-feira (5), a Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) emitiu recomenda\u00e7\u00e3o final favor\u00e1vel \u00e0 incorpora\u00e7\u00e3o do succinato de ribociclibe ao SUS, em associa\u00e7\u00e3o aos inibidores de aromatase n\u00e3o esteroidais, para o tratamento adjuvante de pacientes com c\u00e2ncer de mama inicial RH+\/HER2\u2212, com comprometimento dos linfonodos e alto risco de recorr\u00eancia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">O resultado representa um avan\u00e7o na defesa do acesso a tratamentos oncol\u00f3gicos e destaca a import\u00e2ncia da participa\u00e7\u00e3o social nas decis\u00f5es sobre pol\u00edticas p\u00fablicas de sa\u00fade. Durante a Consulta P\u00fablica sobre o medicamento, a FEMAMA mobilizou as associa\u00e7\u00f5es integrantes de sua Rede para participar do processo. Ao final, foram cerca de 26 mil respostas.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A recomenda\u00e7\u00e3o final favor\u00e1vel representa uma mudan\u00e7a da avalia\u00e7\u00e3o preliminar da Conitec, que havia sido desfavor\u00e1vel \u00e0 incorpora\u00e7\u00e3o. Nesse intervalo, novas evid\u00eancias cient\u00edficas foram apresentadas, incluindo resultados atualizados do estudo NATALEE, divulgados durante o congresso da Sociedade Europeia de Oncologia M\u00e9dica (ESMO), em outubro.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A mobiliza\u00e7\u00e3o tamb\u00e9m esteve presente na reuni\u00e3o de avalia\u00e7\u00e3o final da Conitec, com a participa\u00e7\u00e3o da Liga Mossoroense de Estudos e Combate ao C\u00e2ncer, associa\u00e7\u00e3o integrante da Rede FEMAMA, que levou a perspectiva das organiza\u00e7\u00f5es de pacientes \u00e0s discuss\u00f5es.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Com a recomenda\u00e7\u00e3o favor\u00e1vel, o processo segue para a decis\u00e3o do Minist\u00e9rio da Sa\u00fade. A FEMAMA continuar\u00e1 acompanhando as pr\u00f3ximas etapas e atuando em defesa da amplia\u00e7\u00e3o do acesso ao tratamento para as pacientes eleg\u00edveis no SUS.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Na \u00faltima quinta-feira (5), a Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) emitiu recomenda\u00e7\u00e3o final favor\u00e1vel \u00e0 incorpora\u00e7\u00e3o do succinato de ribociclibe ao SUS, em associa\u00e7\u00e3o aos inibidores de aromatase n\u00e3o esteroidais, para o tratamento adjuvante de pacientes com c\u00e2ncer de mama inicial RH+\/HER2\u2212, com comprometimento dos linfonodos e alto [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":29809,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-29807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"Na \u00faltima quinta-feira (5), a Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) emitiu recomenda\u00e7\u00e3o final favor\u00e1vel \u00e0 incorpora\u00e7\u00e3o do succinato de ribociclibe ao SUS, em associa\u00e7\u00e3o aos inibidores de aromatase n\u00e3o esteroidais, para o tratamento adjuvante de pacientes com c\u00e2ncer de mama inicial RH+\/HER2\u2212, com comprometimento dos linfonodos e alto [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T19:08:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-09T19:23:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1140\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS\",\"datePublished\":\"2026-11-09T19:08:33+00:00\",\"dateModified\":\"2026-11-09T19:23:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/\"},\"wordCount\":292,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento.png\",\"articleSection\":[\"Advocacy\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/\",\"name\":\"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento.png\",\"datePublished\":\"2026-11-09T19:08:33+00:00\",\"dateModified\":\"2026-11-09T19:23:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Capa-Autoconhecimento.png\",\"width\":1140,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/advocacy\\\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/","og_locale":"pt_BR","og_type":"article","og_title":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA","og_description":"Na \u00faltima quinta-feira (5), a Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) emitiu recomenda\u00e7\u00e3o final favor\u00e1vel \u00e0 incorpora\u00e7\u00e3o do succinato de ribociclibe ao SUS, em associa\u00e7\u00e3o aos inibidores de aromatase n\u00e3o esteroidais, para o tratamento adjuvante de pacientes com c\u00e2ncer de mama inicial RH+\/HER2\u2212, com comprometimento dos linfonodos e alto [&hellip;]","og_url":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2026-11-09T19:08:33+00:00","article_modified_time":"2026-11-09T19:23:30+00:00","og_image":[{"width":1140,"height":500,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS","datePublished":"2026-11-09T19:08:33+00:00","dateModified":"2026-11-09T19:23:30+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/"},"wordCount":292,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png","articleSection":["Advocacy"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/","url":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/","name":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png","datePublished":"2026-11-09T19:08:33+00:00","dateModified":"2026-11-09T19:23:30+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2026\/11\/Capa-Autoconhecimento.png","width":1140,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/advocacy\/vitoria-de-advocacy-mobilizacao-da-femama-fortalece-recomendacao-favoravel-ao-ribociclibe-no-sus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Vit\u00f3ria de advocacy: mobiliza\u00e7\u00e3o da FEMAMA fortalece recomenda\u00e7\u00e3o favor\u00e1vel ao ribociclibe no SUS"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=29807"}],"version-history":[{"count":1,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29807\/revisions"}],"predecessor-version":[{"id":29808,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/29807\/revisions\/29808"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/29809"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=29807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=29807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=29807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}